DEUTSCHE BANK AG\ - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$65,903,000
+23.6%
1,842,541
-10.2%
0.04%
+24.2%
Q3 2014$53,340,000
-41.7%
2,051,829
-25.9%
0.03%
-46.8%
Q2 2014$91,570,000
+33.0%
2,770,814
+20.4%
0.06%
+26.5%
Q1 2014$68,856,000
-9.8%
2,300,815
-8.5%
0.05%
-10.9%
Q4 2013$76,328,000
+13.5%
2,514,871
+18.9%
0.06%
+10.0%
Q3 2013$67,254,0002,114,4440.05%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders